1Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int, 2000;58(3) :925-43.
2Murphy JE, Rheinwald JG. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy. Hum Gene Ther, 1997;8(16) :1867-79.
3Jackman RW, Stapleton TD, Masse EM et al. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium in vivo : directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin. Hum Gene Ther,1998;9(7) :1069-81.
4Gokal R. Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J Am Soc Nephrol,2002; 13 (Suppl 1) : 104-16.
5Wang T, Chen C, Heimburger O et al. Hyaluronan prevents the decreased net ultrafiltration caused by increased dialysate fill volume. Kidney Int, 1998;53(2) :496-502.
6Yung S, Thomas GJ, Davies M. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro. Kidney Int, 2000;58(5) : 1953-62.
7Margetts PJ, Gyorffy S, Kolb M et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol, 2002;13(3):721-8.
8Tomita N, Morishita R, Tomita Set al. Transcription factor decoy for NFкB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo. Gene Ther, 2000;7(15): 1326-32.
9Oettinger C, D'Souza M, Iversen Pet al. Microencapsulated(M) antisense (AS) oligomers (O) to NFкB: a new approach to pro-inflammatory (P) cytokine (C) inhibition (Abstract). J Am Soc Nephrol, 2000;11:497A.
10Jackman RW, Hoff CM, Shockley TR et al. Adenovirus-mediated transfer of rat catalase cDNA into rat primary mesothelial cells confers increased resistance to oxidant-induced injury in vitro (Abstract). J Am Soc Nephrol, 1999;10:446A-7A.
